Request Deal Involvement

Sofinnova Partners led a $105m Series B round in Purespring Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Consilium Strategic Communications

pr advisors

Consilium Strategic Communications

Cooley

legal advisors

Cooley

or

Principals

SYNCONA LTD

bidder

SYNCONA LTD

BRITISH PATIENT CAPITAL

bidder

BRITISH PATIENT CAPITAL

FORBION CAPITAL PARTNERS

bidder

FORBION CAPITAL PARTNERS

PURESPRING THERAPEUTICS

target

PURESPRING THERAPEUTICS

SOFINNOVA PARTNERS

bidder

SOFINNOVA PARTNERS

GILDE HEALTHCARE

bidder

GILDE HEALTHCARE

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Sofinnova Partners led a $105m Series B round in Purespring Therapeutics.